The acute ischemic stroke diagnosis market size is expected to see strong growth in the next few years. It will grow to $2.99 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to remote monitoring technologies, patient-centric healthcare models, integration of wearable devices, point-of-care testing devices, expansion of mobile stroke units. Major trends in the forecast period include advancements in imaging technologies, advancements in artificial intelligence, genetic and biomarker product innovations, blockchain for data security, integration of augmented reality.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/acute-ischemic-stroke-diagnosis-global-market-report
Segmentation & Regional Insights
The acute ischemic stroke diagnosis market covered in this report is segmented –
1) By Diagnostic Type: Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography (ECG), Echocardiography, Other Diagnostics
2) By Surgery Type: Carotid Endarterectomy, Angioplasty, Endovascular Mechanical Thrombectomy
3) By Application: Tissue Plasminogen Activator (TPA), Anticoagulant, Antiplatelet, Antihypertensive
North America was the largest region in the acute ischemic stroke diagnosis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute ischemic stroke diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12150&type=smp
Major Driver Impacting Market Growth
The rising prevalence of acute ischemic stroke cases is expected to propel the growth of the acute ischemic stroke diagnosis market going forward. Acute ischemic stroke refers to a severe medical emergency brought on by poor blood supply to the brain, which causes brain cell destruction. Early diagnosis of acute ischemic stroke will aid in treatment and reduce brain damage and other consequences resulting from the stroke. For instance, in March 2023, according to the Centers for Disease Control and Prevention, a US-based national public health agency, stroke deaths increased from 38.8 per 100,000 in 2020 to 41.1 per 100,000 in 2021. Further, in the United States, there are more than 795,000 strokes per year; 610,000 are first-time strokes and ischemic strokes, in which blood flow to the brain is impeded, account for around 87% of all strokes. Therefore, the rising prevalence of acute ischemic stroke cases is driving the growth of the acute ischemic stroke diagnosis market.
Key Industry Players
Major companies operating in the acute ischemic stroke diagnosis market report are Cardinal Health Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Sanofi-Aventis LLC, Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Philips Healthcare, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Genentech Inc., Nihon Kohden Corporation, Neusoft Medical Systems Co. Ltd., Penumbra Inc., Insera Therapeutics LLC, MicroVention Inc., FUJIFILM Medical Systems, Canon Medical Systems Corporation, Silk Road Medical Inc., Samsung Neurologica Corporation, Mentice AB, NICO Corporation, Imperative Care Inc., Olea Medical, NovaSignal Corporation, iSchemaView Inc., Hyperfine Research Inc., Perfuze Ltd.
The acute ischemic stroke diagnosis market report table of contents includes:
1. Executive Summary
2. Acute Ischemic Stroke Diagnosis Market Characteristics
3. Acute Ischemic Stroke Diagnosis Market Trends And Strategies
4. Acute Ischemic Stroke Diagnosis Market – Macro Economic Scenario
5. Global Acute Ischemic Stroke Diagnosis Market Size and Growth
…………………………….
32. Global Acute Ischemic Stroke Diagnosis Market Competitive Benchmarking
33. Global Acute Ischemic Stroke Diagnosis Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Acute Ischemic Stroke Diagnosis Market
35. Acute Ischemic Stroke Diagnosis Market Future Outlook and Potential Analysis
36. Appendix
Explore the trending research reports from TBRC:
https://goodprnews.com/workplace-stress-management-global-market-size/
https://goodprnews.com/breast-cancer-monoclonal-antibodies-global-market-size/
https://goodprnews.com/drugs-for-immunotherapy-global-market-size/
https://topprnews.com/workplace-stress-management-global-market-share/
https://topprnews.com/breast-cancer-monoclonal-antibodies-global-market-share/
https://topprnews.com/drugs-for-immunotherapy-global-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
